Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dorzotimol vs Cosopt in POAG
NCT05973318Phase 3Completed
- Sponsor
- JGL Group
- Start
- Apr 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dorzolamide + timolol in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by JGL Group. Started Apr 2017; status: completed.
02
Drugs
dorzolamide + timolol
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT05973318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05973318.